Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 3825

Astronomers from the University of Texas and the University of Arizona have discovered a rapidly growing black hole in one of the most extreme galaxies known in the very early universe. The discovery of the galaxy and the black hole at its center provides new clues on the formation of the very first supermassive black holes. The new work is published in Monthly Notices of the Royal Astronomical Society.

Using observations taken with the Atacama Large Millimeter Array (ALMA), a radio observatory sited in Chile, the team have determined that the galaxy, named COS-87259, containing this new is very extreme, forming stars at a rate 1,000 times that of our own Milky Way and containing over a billion worth of . The galaxy shines bright from both this intense burst of star formation and the growing supermassive black hole at its center.

The black hole is considered to be a new type of primordial black hole—one heavily enshrouded by cosmic “dust,” causing nearly all of its light to be emitted in the mid-infrared range of the electromagnetic spectrum. The researchers have also found that this growing supermassive black hole (frequently referred to as an ) is generating a strong jet of material moving at near light speed through the host galaxy.

Read more | >

“People on metformin have 30% lower rates of almost every kind of cancer. It delays cognitive decline. Even people with diabetes who are obese and have more disease to start with but are on metformin have lower mortality rates than people without diabetes who aren’t on the drug.”

What he says is born out in numerous studies. Overall, this safe, super-cheap, decades-old drug not only treats diabetes, but it also seems to delay and compress the years of chronic illness associated with the final stage of life and extend what geroscientists call the “healthspan.”

Metformin is just one of many medications, including other old ones and some brand new inventions, that academic researchers and biotech startups are exploring to slow, stop, or perhaps even reverse aging.

Read more | >

AI might not take your job any time soon, but companies are already using it to help them decide who to lay off.

That’s according to a November Capterra survey of 300 US human resources leaders, which found that 98% of respondents plan to use software and algorithms to help them make any layoff decisions in 2023.

While many companies have access to a wide range of employee data — including information on employee attendance, pay, and experience — the HR leaders said “skills” and “performance” data would be most likely to be used in a layoff decision, with 70% of the leaders saying each of these would be considered.

Read more | >

Several studies have predicted that the water splitting reaction could be catalyzed by certain groups of 2D materials—each measuring just a few atoms thick. One particularly promising group are named 2D Janus materials, whose two sides each feature a different molecular composition.

Through new calculations detailed in The European Physical Journal B, Junfeng Ren and colleagues at Shandong Normal University in China present a new group of four 2D Janus materials, which could be especially well suited to the task.

Since hydrogen releases an abundance of energy when combusted, with only water as a byproduct, it is now widely seen as an excellent alternative to fossil fuels. Splitting involves a , where and holes participate in reduction and oxidation reactions.

Read more | >

For the first time, a researcher at the University of Delaware College of Health Sciences in collaboration with a team at the National Institute on Aging, a division of the National Institutes of Health, has determined that the naturally occurring dietary supplement known as nicotinamide riboside (NR) can enter the brain.

The discovery was made by Christopher Martens, assistant professor of kinesiology and applied physiology and director of the Delaware Center for Cognitive Aging Research, and Dr. Dimitrios Kapogiannis, a senior investigator at the National Institute on Aging. The finding is significant because it supports the idea that NR, upon reaching the brain, can alter the metabolism of relevant biological pathways involved in like Alzheimer’s. Their work was recently published in the journal Aging Cell.

Upon consumption, NR is readily converted into nicotinamide adenine dinucleotide (NAD+), which is critical to cellular repair and the repair of damaged DNA.

Read more | >